Reuters
Published Oct 16, 2019 13:54
US STOCKS-Futures slip on renewed U.S-China trade war concerns
(For a live blog on the U.S. stock market, click LIVE/ or
type LIVE/ in a news window.)
* Futures off: Dow 0.19%, S&P 500 0.19%, Nasdaq 0.20%
By Shreyashi Sanyal and Arjun Panchadar
Oct 16 (Reuters) - U.S. stock index futures dipped on
Wednesday as a new U.S. bill taking a hard line on China stoked
fresh concerns about a prolonged trade war, but more positive
results from the banking sector provided some relief and
signaled a solid start to the third-quarter earnings season.
Bank of America BAC.N , the second-largest U.S. bank by
assets, rose 2.2% in premarket trading after beating
third-quarter profit estimates. This followed upbeat results on Tuesday from major U.S.
banks JPMorgan Chase & Co JPM.N , Citigroup Inc C.N and
healthcare giants Johnson & Johnson JNJ.N and UnitedHealth
Group Inc UNH.N .
Tech heavyweights Netflix Inc NFLX.O and International
Business Machines IBM.N are due to report later on Wednesday.
Analysts have forecast a 3% drop in third-quarter earnings
for S&P 500 companies, projecting their worst quarterly
performance in nearly three years, according to Refinitiv data.
The U.S. House of Representatives passed legislation on
Tuesday related to pro-democracy protests in Hong Kong and the
extradition of a Chinese telecom executive. In response, China
warned that bilateral relations would be damaged if the measures
became law. The two countries have been embroiled in a tit-for-tat
tariff war that has taken a toll on financial markets in the
past 15 months and dented growth in the global economy. Last
week, U.S. President Donald Trump announced a partial trade
deal, but it did not include concrete details.
At 7:22 a.m. ET, Dow e-minis 1YMcv1 were down 51 points,
or 0.19%. S&P 500 e-minis EScv1 were down 5.75 points, or
0.19% and Nasdaq 100 e-minis NQcv1 were down 16.25 points, or
0.2%.
A Commerce Department report at 8:30 a.m. ET is likely to
show U.S. retail sales rising 0.3% in September, after a 0.4%
gain in August.
Among other stocks, Achillion Pharmaceuticals Inc ACHN.O
surged 86.8% after drugmaker Alexion Pharmaceuticals Inc
ALXN.O agreed to buy the biotech firm in a deal initially
valued at $930 million. PNC Financial Services Group Inc PNC.N gained 0.3% after
the regional bank beat Wall Street estimates for quarterly
profit. Eli Lilly and Co LLY.N fell 1.5% after the drugmaker said
its experimental pancreatic cancer treatment in combination with
a cocktail of chemotherapies did not meet the main goal in a
late-stage study.
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.